REAL-LIFE PERSISTENCE, EFFECTIVENESS AND SAFETY OF FREMANEZUMAB IN PATIENTS WITH CHRONIC MIGRAINE.

MLA

Ojeda, S., et al. “Real-Life Persistence, Effectiveness and Safety of Fremanezumab in Patients with Chronic Migraine.” European Journal of Hospital Pharmacy, vol. 31, Mar. 2024, pp. A95–96. EBSCOhost, https://doi.org/10.1136/ejhpharm-2024-eahp.195.

APA

Ojeda, S., Riera, P., Pagès, N., Masip, M., Pelegrin, R., & De Dios, A. (2024). Real-Life Persistence, Effectiveness and Safety of Fremanezumab in Patients with Chronic Migraine. European Journal of Hospital Pharmacy, 31, A95–A96. https://doi.org/10.1136/ejhpharm-2024-eahp.195

Chicago

Ojeda, S., P. Riera, N. Pagès, M. Masip, R. Pelegrin, and A. De Dios. 2024. “Real-Life Persistence, Effectiveness and Safety of Fremanezumab in Patients with Chronic Migraine.” European Journal of Hospital Pharmacy 31 (March): A95–96. doi:10.1136/ejhpharm-2024-eahp.195.